Most supplement pages make big promises and cite nothing. I'd rather be straight with you about what the research does and doesn't show.
Cistanche has a long traditional record and a growing body of laboratory and preliminary research into its main compounds — echinacoside, acteoside, the wider phenylethanoid glycosides, and the polysaccharides. Most of that work is in cells or animals. As of 2026 there is exactly one randomized human trial with a performance outcome, plus human safety data. That is the honest shape of it.
Early research is not a promise
What a compound does in a lab or a rodent does not guarantee the same result in your body. Nothing here is medical advice, and cistanche is not intended to diagnose, treat, cure, or prevent any disease. Talk to your doctor before starting any supplement.
Human evidence: the complete list
This section is short on purpose, because the human record is short.
- Tao et al. (2025) — randomized controlled trial; C. deserticola, 5 g raw daily for eight weeks; healthy adults. Improved muscle strength and endurance; reduced exercise-induced cortisol and creatine kinase. The 5 g raw dose is roughly 250 mg of a 20:1 concentrated extract.
- Safety and tolerability study — C. tubulosa extract at up to 1,800 mg per day for 12 weeks; no significant adverse effects. Not designed to measure hormonal outcomes.
- Pilot study of a combination product — a proprietary multi-ingredient supplement containing cistanche; small; subjective sexual-function and satisfaction scores in men; no serum testosterone measured. Nothing in it can be attributed to cistanche alone.
- Small multi-herb trials — combination formulas including cistanche reported improved erectile-function scores in mild cases; cistanche's own contribution cannot be isolated.
What has not been shown in humans: that cistanche raises serum testosterone in healthy men; that it improves memory or cognition; that it changes immune outcomes. Every one of those claims on the internet is an extrapolation from animal or cell data. On this site they are labelled that way.
A correction worth being explicit about
You may see cistanche articles cite "a 2019 randomized trial in men aged 40–70 showing a 14.7% testosterone increase." That trial exists — Lopresti et al., 2019 — but it studied ashwagandha, not cistanche. It appears on our cistanche vs ashwagandha page for that reason and nowhere else. No equivalent cistanche trial has been published.
Animal evidence
- Wang et al. (2016), Pharmaceutical Biology — C. tubulosa ethanol extract at 100, 200 and 400 mg/kg in streptozotocin-diabetic rats; raised testosterone; upregulated StAR and CYP11A1. Diabetes suppresses testosterone, so this may reflect restoration rather than elevation above normal. PubMed
- Kong ZL et al. (2018), Frontiers in Pharmacology — echinacoside at 80, 160 and 320 mg/kg in animal models of reproductive function; dose-response established; confirmed the echinacoside–StAR mechanism with isolated compound.
- Wong KL et al. (2015), Journal of Ethnopharmacology — improved mounting frequency and intromission latency in male rats. Behavioral markers; testosterone not measured directly.
- 2012 study — C. deserticola extract increased testosterone and improved spermatogenesis in cyclophosphamide-treated rats (a chemically suppressed model).
- Wu et al. (2014), BMC Complementary and Alternative Medicine — aqueous C. tubulosa extract reversed behavioral and memory deficits in an Alzheimer's-like rat model. PubMed
- Echinacoside and dopaminergic neurons — protection of dopaminergic neurons in models relevant to Parkinson's research.
- Forced-swim anti-fatigue studies — cistanche extract extended time to exhaustion in mice; mitochondrial function proposed as the mechanism.
- Zhang et al. (2014), Evidence-Based Complementary and Alternative Medicine — C. deserticola extracts countered immunosenescence and extended lifespan markers in accelerated-aging mice. PubMed
- Senescence-accelerated mouse studies — slowed age-related decline across organ systems and improved skin-elasticity markers.
- Ovariectomized-rat bone studies — maintained bone density and stimulated osteoblast proliferation in a post-menopausal bone-loss model.
- Gu C et al. (2016), Chinese Journal of Integrative Medicine — renoprotective effects of C. tubulosa.
- C. salsa and benign prostatic hyperplasia — reduced prostate weight, lowered serum DHT, inhibited 5α-reductase type 1 and 2 expression in BPH models. A different species from the tubulosa in most supplements.
- Toxicology, Regulatory Toxicology and Pharmacology — rodent doses up to 4,000 mg/kg; 90-day subchronic study; no mutagenicity, genotoxicity or teratogenicity; LD50 not reached.
- 2019 study, Biomedicine & Pharmacotherapy — acteoside protected Leydig cells against oxidative damage.
Cell and laboratory evidence
- Jiang et al. (2018), Journal of Ethnopharmacology — echinacoside promoted testosterone production in Leydig cell models, dose-dependently, via StAR/CYP11A1.
- Oxidative Medicine and Cellular Longevity — echinacoside protected Leydig cells from hydrogen-peroxide-induced damage.
- Acteoside antioxidant studies — free-radical scavenging and reduced oxidative-stress markers in vitro; among the stronger activities measured for a plant compound.
- Anti-inflammatory studies — reduced TNF-α and IL-6 and inhibited NF-κB signaling in laboratory models.
- Macrophage nitric-oxide study — aqueous extract inhibited nitric-oxide production from inflammatory macrophages; an anti-inflammatory finding, not a vasodilatory one.
- Preliminary HPG-axis work — early signals on LH signaling; not strong enough to build a claim on.
Reviews
- Li et al. (2016), Frontiers in Pharmacology — "Herba Cistanche: One of the Best Pharmaceutical Gifts of Traditional Chinese Medicine." PubMed
- Zhou et al. (2023) — "Analysis of the Active Ingredients and Health Applications of Cistanche." Phenylethanoid glycosides, polysaccharides, iridoids and their applications. PMC
- Lei L et al. (2015), Journal of Traditional Chinese Medicine — pharmacological review of cistanche, including its traditional use for gut motility.
The evidence base, by compound
Echinacoside
Cistanche's flagship phenylethanoid glycoside, and where most of the interest sits: neuroprotection in animal models, testosterone synthesis in Leydig cell models, dose-response in Kong 2018, antioxidant activity in vitro. It is also where the gap between promising lab findings and confirmed human outcomes is widest.
Acteoside (verbascoside)
Studied mainly for antioxidant, anti-inflammatory and cell-protective activity, including protection of Leydig cells. It occurs across several medicinal plants, so much of the research is not cistanche-specific.
Polysaccharides
The large-molecule fraction, studied for immune modulation and immunosenescence (Zhang 2014), gut motility (Lei 2015), and anti-aging markers in mice. Standardizing an extract to a stated polysaccharide percentage is what makes this fraction measurable rather than assumed — one of the four markers in the buying guide.
Traditional use
Roughly two thousand years of documented use as Rou Cong Rong, a kidney yang tonic. Tradition is context, not proof — but it is a large part of why the plant was worth studying.
Two caveats worth repeating: most of the compound research is early and done in cells or animals, and studying an isolated compound is not the same as taking a whole standardized extract. I read the evidence as promising and worth acting on myself — not as settled science.
If a claim anywhere on this site isn't traceable to something on this page, it shouldn't be there. If you spot one that isn't, tell me and I'll fix it.
Where to go next
The benefits page walks through twelve benefit areas with these citations attached. The testosterone page goes study by study through the hormonal evidence. The side effects page covers the safety data.
Ready to see what a real extract looks like?
The four quality markers, and the one I actually take.
See what I take daily